Antares Pharma intends to price public offering of its common shares

Bookrunners Jefferies and Oppenheimer have a 30-day greenshoe option

By Devika Patel

Knoxville, Tenn., Oct. 2 - Antares Pharma, Inc. will price a public offering of common stock with a 30-day greenshoe option, according to a preliminary prospectus supplement filed Tuesday with the Securities and Exchange Commission.

Jefferies and Oppenheimer & Co. are the joint bookrunning managers.

Proceeds will be used for development of the VIBEX methotrexate Medi-Jet injection system and the VIBEX QS T product and general corporate purposes.

Located in Ewing, N.J., Antares is a pharmaceutical company focused on self-injection pharmaceutical products and technologies and topical gel-basexd products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.